ccRCC is characterized by widespread loss of 3p and amplification of 5q fragments, and genes encoded by 3p fragments (e.g., PBRM1, BAP1, and SETD2) are frequently mutated and closely correlated to altered prognosis (26). This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.